Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 17, 2012British Journal of CancerOpen Access

The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression

View Full Paper
Ask AI
Bookmark
Share

Authors

JHJulia M. HouthuijzenThe Netherlands Cancer InstituteLDLaura G.M. DaenenUtrecht UniversityJRJeanine M.L. RoodhartUniversity Medical Center Utrecht

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Houthuijzen et al. (2012) studied this question.

synapsesocial.com/papers/6a7d1b0c2c71273e4183d774https://doi.org/10.1038/bjc.2012.201
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells2010 · 64 citations
  2. 2Purification of Stearidonic Acid (18:4(n-3)) and Hexadecatetraenoic Acid (16:4(n-3)) from Algal Fatty Acid with Lipase and Medium Pressure Liquid Chromatography2000 · 42 citations
  3. 3The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance2008 · 525 citations
  4. 4CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells2008 · 210 citations
  5. 5Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL122010 · 113 citations